Literature DB >> 17767686

Combining the Memory Impairment Screen and the Isaacs Set Test: a practical tool for screening dementias.

Gilles Chopard1, Alexandre Pitard, Sabrina Ferreira, Geraldine Vanholsbeeck, Lucien Rumbach, Jean Galmiche.   

Abstract

OBJECTIVES: To assess the accuracy of combining the Memory Impairment Screen (MIS) with the Isaacs Set Test (IST) in distinguishing subjects with dementia from controls without dementia.
DESIGN: The weighted sum of MIS and IST scores was calculated, and the logical "or" rule combination was performed using two different patient and control samples. Combination results were compared with each test used alone and with Mini-Mental State Examination to detect all types of dementias.
SETTING: Database of the Regional Network for Diagnostic Aid and Management of Patients with Cognitive Impairment in the Franche-Comté, France, geographical area. PARTICIPANTS: A cohort of 444 patients with Alzheimer's disease, non-Alzheimer's dementia, and reversible dementia and 311 controls. MEASUREMENTS: Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for the combination of these two tests.
RESULTS: The weighted sum had overall sensitivities of 0.92 and 0.84 for mild cases, with a specificity of 0.92. The "or" rule had overall sensitivities of 0.92 and 0.89 for mild cases, with a specificity of 0.90. This pairing requires no more than 5 minutes. Its scoring is simple with the "or" rule combination.
CONCLUSIONS: The combination of MIS and IST could be a useful tool for screening dementias. The "or" rule combination seems particularly adapted to medical practice.

Entities:  

Mesh:

Year:  2007        PMID: 17767686     DOI: 10.1111/j.1532-5415.2007.01271.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  1 in total

1.  Early post-operative cognitive dysfunction after closed-loop versus manual target controlled-infusion of propofol and remifentanil in patients undergoing elective major non-cardiac surgery: Protocol of the randomized controlled single-blind POCD-ELA trial.

Authors:  Guillaume Besch; Lucie Vettoretti; Melanie Claveau; Nathalie Boichut; Nicolas Mahr; Yannis Bouhake; Ngai Liu; Thierry Chazot; Emmanuel Samain; Sebastien Pili-Floury
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.